Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14698 | 686 | 50.5 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROINFLAMMAT S | Address | 4 | 31% | 2% | 11 |
2 | MOL NEUROSCI UNIT | Address | 3 | 29% | 1% | 10 |
3 | BUTAPROST | Author keyword | 3 | 32% | 1% | 7 |
4 | BRAIN PHYSIOL METAB SECT | Address | 2 | 10% | 3% | 22 |
5 | CIEB IFAL | Address | 2 | 67% | 0% | 2 |
6 | INDUCIBLE NITRIC OXIDE SYNTHASE NULL MICE | Author keyword | 2 | 67% | 0% | 2 |
7 | MURINE ASTROCYTES | Author keyword | 2 | 67% | 0% | 2 |
8 | PHENYL BUTYL NITRONE | Author keyword | 2 | 67% | 0% | 2 |
9 | PROSTAGLANDIN ETHANOLAMIDES | Author keyword | 2 | 67% | 0% | 2 |
10 | PROSTAGLANDIN GLYCEROL ESTERS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUTAPROST | 3 | 32% | 1% | 7 | Search BUTAPROST | Search BUTAPROST |
2 | INDUCIBLE NITRIC OXIDE SYNTHASE NULL MICE | 2 | 67% | 0% | 2 | Search INDUCIBLE+NITRIC+OXIDE+SYNTHASE+NULL+MICE | Search INDUCIBLE+NITRIC+OXIDE+SYNTHASE+NULL+MICE |
3 | MURINE ASTROCYTES | 2 | 67% | 0% | 2 | Search MURINE+ASTROCYTES | Search MURINE+ASTROCYTES |
4 | PHENYL BUTYL NITRONE | 2 | 67% | 0% | 2 | Search PHENYL+BUTYL+NITRONE | Search PHENYL+BUTYL+NITRONE |
5 | PROSTAGLANDIN ETHANOLAMIDES | 2 | 67% | 0% | 2 | Search PROSTAGLANDIN+ETHANOLAMIDES | Search PROSTAGLANDIN+ETHANOLAMIDES |
6 | PROSTAGLANDIN GLYCEROL ESTERS | 2 | 67% | 0% | 2 | Search PROSTAGLANDIN+GLYCEROL+ESTERS | Search PROSTAGLANDIN+GLYCEROL+ESTERS |
7 | SC 51089 | 2 | 67% | 0% | 2 | Search SC+51089 | Search SC+51089 |
8 | NS398 | 2 | 19% | 1% | 7 | Search NS398 | Search NS398 |
9 | BUDESONIDE EPIMER R | 1 | 100% | 0% | 2 | Search BUDESONIDE+EPIMER+R | Search BUDESONIDE+EPIMER+R |
10 | EP2 | 1 | 13% | 1% | 9 | Search EP2 | Search EP2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEURONAL CYCLOOXYGENASE 2 | 21 | 85% | 2% | 11 |
2 | ACID INDUCED SEIZURE | 18 | 59% | 3% | 20 |
3 | INDUCIBLE CYCLOOXYGENASE | 11 | 12% | 13% | 87 |
4 | CONTROL BRAIN | 9 | 64% | 1% | 9 |
5 | PGE2 EP2 RECEPTOR | 8 | 42% | 2% | 14 |
6 | BETA PHAGOCYTOSIS | 6 | 71% | 1% | 5 |
7 | NEURONAL OXIDATIVE DAMAGE | 4 | 47% | 1% | 7 |
8 | PROSTAGLANDIN RECEPTOR EP2 | 3 | 50% | 1% | 5 |
9 | CELL CYCLE ACTIVITY | 3 | 35% | 1% | 8 |
10 | G H SYNTHASE 2 CYCLOOXYGENASE 2 | 3 | 57% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research | 2009 | 104 | 73 | 38% |
Emerging roles of PGE(2) receptors in models of neurological disease | 2010 | 58 | 151 | 37% |
Targeting cyclooxygenases-1 and-2 in neuroinflammation: Therapeutic implications | 2011 | 39 | 46 | 37% |
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease | 2014 | 8 | 117 | 23% |
Roles of prostaglandin synthesis in excitotoxic brain diseases | 2007 | 43 | 56 | 50% |
Cyclooxygenase inhibition in ischemic brain injury | 2008 | 45 | 289 | 47% |
Cyclooxygenase-1 and-2 in the different stages of Alzheimer's disease pathology | 2008 | 58 | 103 | 35% |
Role of Inflammatory Mediators in the Pathogenesis of Epilepsy | 2014 | 3 | 76 | 34% |
Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection | 2013 | 16 | 119 | 24% |
Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease | 2011 | 22 | 53 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROINFLAMMAT S | 4 | 31% | 1.6% | 11 |
2 | MOL NEUROSCI UNIT | 3 | 29% | 1.5% | 10 |
3 | BRAIN PHYSIOL METAB SECT | 2 | 10% | 3.2% | 22 |
4 | CIEB IFAL | 2 | 67% | 0.3% | 2 |
5 | TRANSLAT MED OPHTHALMOL | 2 | 67% | 0.3% | 2 |
6 | DISCOVERY 1 | 2 | 40% | 0.6% | 4 |
7 | CIEB | 2 | 31% | 0.7% | 5 |
8 | IFAL | 1 | 19% | 0.7% | 5 |
9 | NEURAL PLAST PROJECT | 1 | 27% | 0.4% | 3 |
10 | DRUG IDR | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000183981 | LEUKOTRIENE C 4 SYNTHESIS DEFICIENCY//HADASSAH MED PHARMACOL//EICOSATETRAYNOIC ACID |
2 | 0.0000173120 | TUMOR NECROSIS FACTOR CONVERTING ENZYME//KINSMEN NEUROL//FIBRILLAR PLAQUE |
3 | 0.0000158787 | MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 2 |
4 | 0.0000142962 | ONO 1301//IP RECEPTOR//EP4 RECEPTOR |
5 | 0.0000112579 | EMERGENCY ACUTA//EXP NEUROL//NEURO PATHOL |
6 | 0.0000112068 | PROSTAGLANDIN H SYNTHASE//IMRECOXIB//AB HANCOCK JR MEM CANC |
7 | 0.0000110657 | BRAIN PHYSIOL METAB SECT//ARACHIDONIC//IN VIVO INCORPORATION |
8 | 0.0000098429 | EP1 ANTAGONIST//VISCERAL NOCICEPTOR//POLYMODAL RECEPTOR |
9 | 0.0000096340 | NEUROPHARMACOL SECT//NEUROANAT EXPT NEUROL//PHARMACOL CHEM |
10 | 0.0000079003 | ADRENOMEDULLARY OUTFLOW//PROGRAM NEURAL INTEGRAT//BRAIN PHOSPHOLIPASE A2 |